• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥散性血管内凝血的微观流变学临床问题(作者译)

[Clinical problems of microrheology in disseminated intravascular coagulation (author's transl)].

作者信息

Hartert H

出版信息

Arzneimittelforschung. 1981;31(11a):2035-9.

PMID:7199294
Abstract

Among the earliest products of a potentially succeeding disseminated intravascular coagulation (DIC) are the soluble fibrin monomer complexes representing a state of hypercoagulability. They are passing microcirculation as long as there are no precipitation activities, which may involve only one single organ. A typical example is the endotoxin shock followed by fibrination of the kidneys. The clogging of microcirculation by fibrination specifically released in this organ or another may be prevented in case of a well-timed diagnosis, but scarcely can be removed therapeutically (possibly therapeutical fibrinolysis). The effects of localising fibrination yet independent of clotting mechanism may be tackled by treating the causal disease. Hypercoagulability always preceding DIC can be controlled mainly by heparin. Its well-timed application depends on diagnostics which are able to define the momentary situation in the mostly progredient process, comprising a mortality of about 50%. Finally, as a possible method to assess the clinical situation the resonance thrombography, a successor of thrombelastography, is put forward.

摘要

潜在的后继弥散性血管内凝血(DIC)最早的产物之一是可溶性纤维蛋白单体复合物,代表高凝状态。只要没有沉淀活动,它们就会通过微循环,沉淀活动可能仅涉及一个单一器官。一个典型的例子是内毒素休克后肾脏发生纤维蛋白沉积。如果诊断及时,可能会防止在该器官或其他器官中特异性释放的纤维蛋白沉积导致微循环阻塞,但几乎无法通过治疗消除(可能是治疗性纤维蛋白溶解)。针对病因疾病进行治疗可以解决与凝血机制无关的局部纤维蛋白沉积的影响。总是先于DIC出现的高凝状态主要可以通过肝素进行控制。其及时应用取决于能够确定这个大多呈进行性发展且死亡率约为50%的过程中当前情况的诊断方法。最后,作为评估临床情况的一种可能方法,提出了共振血栓图,它是血栓弹力图的后继技术。

相似文献

1
[Clinical problems of microrheology in disseminated intravascular coagulation (author's transl)].弥散性血管内凝血的微观流变学临床问题(作者译)
Arzneimittelforschung. 1981;31(11a):2035-9.
2
[Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].[肝素和/或抗凝血酶III在兔内毒素诱导的弥散性血管内凝血模型中的作用]
Sangre (Barc). 1992 Feb;37(1):5-10.
3
[A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].一种用于血栓形成和生命预后的新型分子标志物——可溶性纤维蛋白单体-纤维蛋白原复合物(SF)测定的临床应用价值
Rinsho Byori. 2004 Apr;52(4):355-61.
4
International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.国际血栓与止血学会显性弥散性血管内凝血评分可预测脓毒症患者的器官功能障碍和死亡率。
Blood Coagul Fibrinolysis. 2006 Sep;17(6):445-51. doi: 10.1097/01.mbc.0000240916.63521.2e.
5
[Infected abortion and disseminated intravascular coagulation (DIC). Heparin prevention and early diagnosis of the DIC].[感染性流产与弥散性血管内凝血(DIC)。肝素对DIC的预防及早期诊断]
Med Welt. 1971 Jul 24;22(29):1199-200.
6
[Hemostatic defects in shock (author's transl)].休克中的止血缺陷(作者译)
Verh Dtsch Ges Pathol. 1978;62:103-11.
7
[Asphyxial shock and disseminated intravascular coagulation (DIC) in animal experiments. 2. Morphometric tests and blood coagulation studies (author's transl)].
Zentralbl Gynakol. 1980;102(11):606-15.
8
[DIC (author's transl)].[弥散性血管内凝血(作者译)]
Kokyu To Junkan. 1976 Feb;24(2):96-104.
9
Disseminated intravascular coagulation and a negative D-dimer test.弥散性血管内凝血与D-二聚体检测结果阴性
Neth J Med. 2007 Nov;65(10):398-400.
10
The clinical significance of fibrinogen degradation products.纤维蛋白原降解产物的临床意义。
Semin Thromb Hemost. 1982 Oct;8(4):302-30. doi: 10.1055/s-2007-1005060.